Private Equity
AI Capital Risk for Private Equity Firms
Evaluating AI deployment exposure across portfolio companies before approving capital investments.
Section 1
Why AI Investment Oversight Is Becoming a Portfolio Issue
Private equity firms increasingly encounter artificial intelligence deployment initiatives across portfolio companies.
Management teams often propose AI systems involving operational automation, decision models, or customer-facing applications.
These initiatives may require significant capital investment while introducing governance, regulatory, and operational risks.
Investment committees therefore require structured visibility into AI deployment exposure before approving capital allocation.
Section 2
The Portfolio-Level Challenge
AI initiatives often emerge independently across portfolio companies.
This can create inconsistent governance structures, varying regulatory exposure, and uneven operational readiness across the portfolio.
Without a structured evaluation framework, investment committees may struggle to determine whether proposed AI deployments represent acceptable capital risk.
Private equity firms increasingly require a consistent framework for evaluating AI deployment exposure before approving capital investments.
Section 3
Evaluating AI Capital Risk Across Portfolio Companies
The Stratify™ AI Capital Risk Instrument evaluates exposure associated with AI capital deployment before investment approval.
The instrument assesses exposure across five structural vectors:
- Regulatory and compliance exposure
- Structural governance and oversight maturity
- Data and infrastructure reliability
- Operational execution readiness
- Capital allocation discipline
This evaluation produces an independent AI Capital Risk Determination indicating whether AI capital deployment should proceed.
Section 4
Capital Authorization for AI Investments
The Stratify™ AI Capital Risk Instrument produces a capital authorization posture indicating whether AI capital deployment should proceed.
Pause
AI capital deployment should not proceed until exposure conditions are remediated.
Controlled Investment
AI deployment may proceed within defined governance and operational guardrails.
Authorize Deployment
Exposure conditions support broader AI capital deployment under continued governance discipline.
These determinations provide investment committees with a structured basis for evaluating AI capital allocation decisions.
Section 5
Portfolio Governance Benefits
Applying the Stratify™ AI Capital Risk Instrument across portfolio companies allows private equity firms to:
- standardize evaluation of AI capital investments
- identify governance and regulatory exposure across the portfolio
- reduce the probability of failed AI deployments
- support disciplined capital allocation decisions
This creates consistent oversight of AI capital deployment across the portfolio.
Section 6
Typical Portfolio Evaluations
AI capital investments evaluated
$1M – $10M+
Evaluation timeline
~14 days
Portfolio-wide evaluations available.
Evaluate AI Capital Exposure Across Portfolio Companies
Private equity firms evaluating AI deployment initiatives can request a confidential executive briefing to review the Stratify™ AI Capital Risk Instrument.